BBK Worldwide Launches Expanded Suite Of Retention Products To Support Clinical Trial Study Sites
Only BBK Worldwide’s system is designed to minimize the need for acquiring personal and identifying patient information, a requirement of competitor programs directly resulting in sub-optimal ethics committee and patient support for these necessary retention and compliance services.
Each individual product addresses a specific retention function. The RSG Card is a global reimbursement solution for clinical study participants. “With the RSG Card, we are transforming the way the industry reimburses study participants – making it easier and more efficient for both patients and study staff,” comments Mike Johnson, Product Development, BBK Worldwide. “Management of the card is streamlined at the site level through TrialCentralNetSM, the leading online patient recruitment management system,” continues Johnson.
RSG Ride offers a convenient way to schedule and manage patient transportation. BBK specialists coordinate travel to and from approved study visits, fostering study compliance and minimizing the need for site staff to reschedule missed appointments. “RSG Ride provides an alternative choice in transportation for study participants who may have difficulty finding transportation to and from study appointments,” comments Jennifer Dinkel, Strategic Consultant, BBK Worldwide.
RSG Minder is a customized mobile platform that supports study participants and assists them in managing their study obligations. “Study participants have access to functionality that allows them to track upcoming study visits and schedule convenient reminders. In addition, content functionality allows BBK to send notifications to opted-in patients about upcoming visit reminders, post-visit follow-up, and general study information and updates,” comments Johnson.
To learn more about these and other BBK products, visit
Related Links:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025